Return to the home page. top banner right
top banner bottom
Click to search.
members
Login:
Password:
Click to login
Click for Log In Help
Click to Join the Society
 
 
 
 
Click for the Heart Rhythm Foundation
Click for the IBHRE (formerly NASPExAM)
Click for Professional Education
 
 
 
 
 
 
 
 
Click for Health Policy
Click for News & Information
Click for Scientific Sessions
Click for the HRS Calendar
Click for the HeartRhythm Journal
Click for the HRS Store
Click to Find a Specialist
Click for Patient Information
Click for About HRS
Click for Membership
titlelines Results from the LAPID Trial on Atrial Flutter

Trial: Results from the Loire-Ardeche-Drome-Isere-Puy-de-Dome (LAPID) trial on atrial flutter, a multicenter prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter.

Authors: Da Costa A, Thevenin J, Roche F, Romeyer-Bouchard C, Abdellaoui L, Messier M, Denis L, Faure E, Gonthier R, Kruszynski G, Pages M, Bonijoly S, Lamaison D, Defaye P, Barthelemy C, Gouttard T, Isaaz K, for the Loire-Ardeche-Drome-Isere-Puy-de-Dome (LAPID) trial of atrial flutter investigators.

Reference: Circulation 2006;114:1676-1681

Purpose: To 1) prospectively compare safety and efficacy of first-line radiofrequency ablation versus electrical cardioversion and amiodarone therapy for typical atrial flutter and 2) to determine the long-term impact  of each treatment on the risk of subsequent atrial fibrillation

Number of Patients: 104

Number of Centers: 11

Design: Multicenter, prospective, randomized

Authors Conclusion: Radiofrequency ablation should be considered first line therapy for symptomatic typical atrial flutter even after the first episode. Compared to amiodarone, radiofrequency ablation has a better long term success rate, fewer side effects and the same risk of subsequent atrial fibrillation.

Key words: atrial flutter, radiofrequency catheter ablation, amiodarone, atrial fibrillation

Comment: This study supports the safe and effective role of radiofrequency ablation very early in the course of typical atrial flutter in older subjects (all > 70 years). Amiodarone was not tolerated in 10% of patients. Atrial fibrillation occurrence remains problematic for either strategy.  

Ongoing Related Studies: 

1. Isthmus Ablation with Gold Electrode for Treatment of Atrial Flutter
2. Randomized Study of Radiofrequency vs. Cryo-Ablation for Typical Isthmus-Dependent Atrial Flutter
3. Maximum Targeted Ablation of Atrial Flutter
4. Prevention of Atrial Fibrillation With ARB After Catheter Ablation
5. Catheter Evaluation for Endocardial Ablation in Patients With Typical Atrial Flutter


Summary written by Mark Wood, MD

Click to Print Page.Click to Email Page. Click to Contact Us.Click for the Site Map.
© Heart Rhythm Society      1400 K St NW ste 500      Washington DC 20005      tel 202.464.3400      fax 202.464.3401